首页 > 市场调查报告书 > 医疗设备

体外诊断

欧洲免疫诊断市场预测至 2030 年 - 区域分析 - 按产品（酵素连结免疫吸附测定、化学发光免疫测定、放射免疫测定等）、临床适应症和最终用户

市场调查报告书

商品编码

1402521

欧洲免疫诊断市场预测至 2030 年 - 区域分析 - 按产品（酵素连结免疫吸附测定、化学发光免疫测定、放射免疫测定等）、临床适应症和最终用户

Europe Immunodiagnostics Market Forecast to 2030 - Regional Analysis - by Product (Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays, and Others), By Clinical Indication, and End User

出版日期: 2023年11月07日 | 出版商:

The Insight Partners | 英文 209 Pages | 订单完成后即时交付

价格

简介目录图表

欧洲免疫诊断市场预计将从2023年的61.3185亿美元成长到2030年的100.9803亿美元。预计2023年至2030年CAGR为7.4%。

传染病率的增加推动了欧洲免疫诊断市场

由病毒、真菌、细菌、寄生虫或其有毒产物等感染原引起的几种不断增长的传染病的诊断和治疗，免疫诊断测试的处方数量激增，例如补体结合、沉淀测试、凝集测试、线印迹分析、蛋白质印迹分析、酵素免疫分析(EIA) 和免疫萤光测试。人类免疫缺乏病毒（HIV）仍然是世界范围内的一个主要公共卫生问题。此外，结核病 (TB)、COVID-19 和其他医院获得性感染 (HAIs) 需要进行免疫诊断测试。

结核病已成为第 13 大死因，也是仅次于 COVID-19 的第二大传染病杀手。 2020 年，全球有 150 万人死于结核病，估计有 1,000 万人受到影响，其中包括 560 万名男性、330 万名女性和 110 万名儿童。

据 Worldometer 称，全球报告了数百万人因 COVID-19 大流行而死亡。它给医疗保健系统带来了压力，并增加了对免疫诊断测试的需求。

诊断在确定合适的医疗方法方面发挥着至关重要的作用。免疫诊断有助于诊断严重影响免疫系统的疾病。因此，传染病盛行率的上升导致对免疫诊断产品的需求激增。

欧洲免疫诊断市场概况

庞大的老年人口极大地推动了德国免疫诊断市场的发展。根据联合国人口资料，每20 名德国人中就有1 人年龄在80 岁以上，预计到2050 年，这一数字将增加到每20 人中就有6 人。患慢性疾病的风险，如心血管疾病(CVD)、糖尿病、和神经血管疾病，随着年龄的增长而增加。根据罗伯特·科赫研究所2023年9月发布的德国癌症登记资料中心（ZfKD）估计，2019年德国有502,655人患有癌症，其中女性234,925人，男性267,730人。据估计，由于生活方式的改变、肥胖、不健康的习惯等，癌症的流行可能会持续下去。德国最常见的癌症是乳癌、摄护腺癌、大肠癌（大肠癌）、肺癌和膀胱癌。这五种癌症约占德国所有新诊断癌症的 57%。因此，癌症盛行率的增加可能会推动对免疫诊断的需求。

德国是仅次于美国的世界领先的医疗生物技术国家。与新冠疫情爆发前的 2018 年相比，2020 年德国生物技术产业显着成长。过去几年，一些领域的正面市场趋势已加速；根据BIOCOM符合OECD标准的调查显示，2020年德国生技产业的营业额成长了近50%。老牌企业的存在和新创企业的出现肯定了产业实力。工业、政府和研究部门的蓬勃发展依赖强大的市场基础。德国拥有许多欧洲生物技术公司、世界一流的研究基础设施和国际知名科学家，已牢固确立了其国际医疗生物技术中心的地位。德国生物技术公司推出了欧洲药品管理局批准的首个 COVID-19 检测和疫苗接种，成为 mRNA 技术的全球领导者。这些发展促进了免疫诊断技术的进步。因此，生物技术产业的崛起可能会提振该国的免疫诊断市场。

欧洲免疫诊断市场收入及 2030 年预测（百万美元）

欧洲免疫诊断市场细分

欧洲免疫诊断市场分为产品、临床适应症、最终用户和国家。

根据产品，欧洲免疫诊断市场分为酵素连结免疫吸附测定（ELISA）、化学发光免疫测定（CLIA）、放射免疫测定（RIA）等。 2023年，酵素连结免疫吸附测定（ELISA）领域在欧洲免疫诊断市场占据最大份额。化学发光免疫分析 (CLIA) 领域进一步细分为维生素 D 分析市场、HIV 检测市场、HIV a/ab 组合分析市场和其他测试。

根据临床适应症，欧洲免疫诊断市场分为传染病、肝炎+爱滋病、内分泌、胃肠道、代谢等。 2023年，传染病领域在欧洲免疫诊断市场中占最大份额。传染病细分为 COVID-19、结核病、莱姆病、感染管理、寨卡病毒、密螺旋体、火炬、麻疹和腮腺炎、水痘带状疱疹病毒和 EB 病毒。内分泌科进一步细分为高血压、生长、糖尿病、甲状腺和生殖内分泌。

根据最终用户，欧洲免疫诊断市场分为医院、诊所、诊断实验室、学术和研究机构等。 2023年，医院细分市场在欧洲免疫诊断市场中占据最大份额。

根据国家/地区，欧洲免疫诊断市场分为德国、法国、英国、义大利、西班牙和欧洲其他地区。 2023年，德国市场在欧洲免疫诊断市场占有最大份额。

雅培实验室；生物梅里埃公司；丹纳赫公司； DiaSorin SpA； F.霍夫曼-拉罗氏有限公司；珀金埃尔默公司；深圳迈瑞生物医疗电子有限公司；西门子医疗保健有限公司；斯瓦尔生命科学公司；和 Thermo Fisher Scientific Inc 是欧洲免疫诊断市场上一些领先的公司。

概述
按临床适应症分類的欧洲免疫诊断市场份额 - 2022 年和 2030 年 (%)
传染性疾病：
- 概述
  - 新冠肺炎
  - 结核
  - 莱姆病
  - 感染管理
  - 寨卡病毒
  - 密螺旋体属
  - 火炬
  - 麻疹和腮腺炎
  - VZV
  - EB病毒
肝炎+爱滋病毒：
- 概述
胃肠道
- 概述
代谢紊乱
- 概述
内分泌科
- 概述
- 高血压
  - 概述
- 生长
  - 概述
- 糖尿病
  - 概述
- 甲状腺
  - 概述
- 生殖内分泌学
  - 概述
其他的
- 概述

第 9 章：欧洲免疫诊断市场分析 - 最终用户

概述
按最终用户分類的欧洲免疫诊断市场份额 - 2022 年和 2030 年 (%)
医院
- 概述
诊所
- 概述
诊断实验室
- 概述
学术及研究机构
- 概述
其他的
- 概述

第 10 章：欧洲免疫诊断市场 - 2030 年收入与预测 - 国家分析

概述

第 11 章：欧洲免疫诊断市场 - 产业格局

概述
无机成长策略
- 概述
有机成长策略
- 概述

第 12 章：公司简介

Abbott Laboratories
F. Hoffmann-La Roche Ltd
DiaSorin SpA
Danaher Corp
Thermo Fisher Scientific Inc
PerkinElmer Inc
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
bioMerieux SA
Svar Life Science AB
Siemens Healthcare GmbH

第 13 章：附录

关于 Insight Partners
专业术语

简介目录图表

Product Code: BMIRE00027867

The Europe immunodiagnostics market is expected to grow from US$ 6,131.85 million in 2023 to US$ 10,098.03 million by 2030. It is estimated to grow at a CAGR of 7.4% from 2023 to 2030.

Increasing Prevalence of Infectious Diseases Drive Europe Immunodiagnostics Market

The diagnosis and management of several ever-growing infectious diseases caused by infectious agents such as viruses, fungi, bacteria, parasites, or their toxic products are surging number of prescriptions for immunodiagnostics tests, e.g., complement fixation, precipitation tests, agglutination tests, line blot assays, Western blot assays, enzyme immunoassays (EIA), and immunofluorescence tests. Human immunodeficiency virus (HIV) continues to be a major public health issue worldwide. Further, tuberculosis (TB), COVID-19, and other hospital-acquired infections (HAIs) require immunodiagnostics tests.

TB has been the 13th leading cause of death and the second-leading infectious killer after COVID-19. In 2020, 1.5 million people died from TB and affected an estimated 10 million people, comprising 5.6 million males, 3.3 million females, and 1.1 million children globally.

According to Worldometer, millions of deaths were reported worldwide due to the COVID-19 pandemic. It strained healthcare systems and increased the need for immunodiagnostics tests.

Diagnostics play a vital role in determining suitable medical treatments. Immunodiagnostics help diagnose diseases that severely impact the immune system. Hence, the rising prevalence of infectious diseases lead to the surging demand for immunodiagnostics products.

Europe Immunodiagnostics Market Overview

The huge geriatric population is significantly driving the market for immunodiagnostics in Germany. According to the UN population data, 1 out of 20 Germans is aged above 80 years, and the number is expected to increase to 6 out of 20 by 2050. The risk of developing chronic diseases, such as cardiovascular diseases (CVDs), diabetes, and neurovascular disorders, increases with age. According to the estimates of the German Centre for Cancer Registry Data (ZfKD) published by the Robert Koch Institute in September 2023, in Germany, 502,655 people had cancer in 2019, among which 234,925 were women and 267,730 were men. It is estimated that the prevalence of cancer is likely to continue owing to lifestyle changes, obesity, unhealthy habits, and more. The most common cancers in Germany are breast, prostate, colorectum (large bowel), lung, and bladder cancer. These five cancer types accounted for about 57% of all new cancer diagnoses in Germany. Thus, the increasing prevalence of cancer is likely to propel the demand for immunodiagnostics.

Germany is the leading medical biotech nation in the world after the US. In 2020, the German biotechnology sector grew significantly compared to the pre-COVID year 2018. The positive market trend has accelerated in the last few years in some areas; and according to the OECD-compliant survey by BIOCOM, the German biotechnology industry's turnover increased by almost 50% in 2020. The presence of long-established companies and the emergence of start-ups affirmed the industrial strength. Industry, government, and research sectors thrive on strong market foundations. With many European biotech companies, world-class research infrastructure, and internationally renowned scientists, Germany has firmly established itself as an international medical biotechnology hub. German biotech companies emerged as global leaders in mRNA technologies by introducing the first COVID-19 test and vaccination, approved by the European Medicines Agency. Such developments have encouraged enhanced technological advancements for immunodiagnostics. Thus, the rising biotechnology sector will likely boost the country's immunodiagnostics market.

Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Europe Immunodiagnostics Market Segmentation

The Europe immunodiagnostics market is segmented into product, clinical indication, end user, and country.

Based on product, the Europe immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. In 2023, the enzyme-linked immunosorbent assays (ELISA) segment registered the largest share in the Europe immunodiagnostics market. The chemiluminescence immunoassays (CLIA) segment is further segmented into vitamin D assay market, HIV detection market, HIV ag/ab combo assay market, and other tests.

Based on clinical indication, the Europe immunodiagnostics market is segmented into infectious diseases, hepatitis+hiv, endocrinology, gastrointestinal, metabolics, and others. In 2023, the infectious diseases segment registered the largest share in the Europe immunodiagnostics market. The infectious diseases segment is further segmented into COVID-19, tuberculosis, lyme, infection management, zika, treponema, torch, measles and mumps, VZV, and EBV. The endocrinology segment is further segmented into hypertension, growth, diabetes, thyroid, and reproductive endocrinology.

Based on end user, the Europe immunodiagnostics market is segmented into hospitals, clinics, diagnostic laboratories, academic & research institutes, and others. In 2023, the hospitals segment registered the largest share in the Europe immunodiagnostics market.

Based on country, the Europe immunodiagnostics market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. In 2023, Germany segment registered the largest share in the Europe immunodiagnostics market.

Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin SpA; F. Hoffmann-La Roche Ltd; PerkinElmer Inc; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthcare GmbH; Svar Life Science AB; and Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe immunodiagnostics market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe immunodiagnostics market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe immunodiagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the immunodiagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Immunodiagnostics Market - by Product
- 1.3.2 Europe Immunodiagnostics Market - by Clinical Indication
- 1.3.3 Europe Immunodiagnostics Market - by End User
- 1.3.4 Europe Immunodiagnostics Market - by Country

2. Europe Immunodiagnostics Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Immunodiagnostics Market - Market Landscape

4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert's Opinion

5. Europe Immunodiagnostics Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Infectious Diseases
- 5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
- 5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
- 5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
- 5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis

6. Immunodiagnostics Market - Europe Analysis

6.1 Europe Immunodiagnostics Market Revenue Forecast and Analysis

7. Europe Immunodiagnostics Market Analysis - by Product

7.1 Overview
7.2 Europe Immunodiagnostics Market, By Product, 2022 & 2030 (%)
7.3 Enzyme-linked Immunosorbent Assays (ELISA)
- 7.3.1 Overview
- 7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4 Chemiluminescence Immunoassays (CLIA)
- 7.4.1 Overview
- 7.4.2 Chemiluminescence Immunoassays (CLIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 Vitamin D Assay
  - 7.4.3.1 Overview
  - 7.4.3.2 Vitamin D Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 HIV Detection
  - 7.4.4.1 Overview
  - 7.4.4.2 HIV Detection: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.5 HIV Ag/Ab Combo assay
  - 7.4.5.1 Overview
  - 7.4.5.2 HIV Ag/Ab Combo Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.6 Other Tests
  - 7.4.6.1 Overview
  - 7.4.6.2 Other Tests: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Radioimmunoassays (RIA)
- 7.5.1 Overview
- 7.5.2 Radioimmunoassays (RIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8. Europe Immunodiagnostics Market Analysis - Clinical Indication

8.1 Overview
8.2 Europe Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
8.3 Infectious Diseases:
- 8.3.1 Overview
- 8.3.2 Infectious Diseases: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 COVID-19
    - 8.3.2.1.1 Overview
    - 8.3.2.1.2 COVID-19: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.2 Tuberculosis
    - 8.3.2.2.1 Overview
    - 8.3.2.2.2 Tuberculosis: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.3 Lyme
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Lyme: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.4 Infection Management
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Infection Management: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.5 Zika
    - 8.3.2.5.1 Overview
    - 8.3.2.5.2 Zika: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.6 Treponema
    - 8.3.2.6.1 Overview
    - 8.3.2.6.2 Treponema: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.7 TORCH
    - 8.3.2.7.1 Overview
    - 8.3.2.7.2 TORCH: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.8 Measles and Mumps
    - 8.3.2.8.1 Overview
    - 8.3.2.8.2 Measles and Mumps: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.9 VZV
    - 8.3.2.9.1 Overview
    - 8.3.2.9.2 VZV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.10 EBV
    - 8.3.2.10.1 Overview
    - 8.3.2.10.2 EBV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.4 Hepatitis+HIV:
- 8.4.1 Overview
- 8.4.2 Hepatitis+HIV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Gastrointestinal
- 8.5.1 Overview
- 8.5.2 Gastrointestinal: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.6 Metabolic Disorders
- 8.6.1 Overview
- 8.6.2 Metabolics: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7 Endocrinology
- 8.7.1 Overview
- 8.7.2 Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.3 Hypertension
  - 8.7.3.1 Overview
  - 8.7.3.2 Hypertension: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.4 Growth
  - 8.7.4.1 Overview
  - 8.7.4.2 Growth: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.5 Diabetes
  - 8.7.5.1 Overview
  - 8.7.5.2 Diabetes: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.6 Thyroid
  - 8.7.6.1 Overview
  - 8.7.6.2 Thyroid: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.7 Reproductive Endocrinology
  - 8.7.7.1 Overview
  - 8.7.7.2 Reproductive Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9. Europe Immunodiagnostics Market Analysis - End User

9.1 Overview
9.2 Europe Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Clinics
- 9.4.1 Overview
- 9.4.2 Clinics: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 Diagnostic Laboratories: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.6 Academic and Research Institutes
- 9.6.1 Overview
- 9.6.2 Academic and Research Institutes: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

10. Europe Immunodiagnostics Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Overview

11. Europe Immunodiagnostics Market -Industry Landscape

11.1 Overview
11.2 Inorganic Growth Strategies
- 11.2.1 Overview
11.3 Organic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 DiaSorin SpA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Danaher Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 PerkinElmer Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 bioMerieux SA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Svar Life Science AB
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Siemens Healthcare GmbH
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. UK Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 2. UK Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 3. UK Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 4. UK Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 5. UK Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 6. UK Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 7. Germany Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 8. Germany Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 9. Germany Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 10. Germany: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 11. Germany Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 12. Germany Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. France Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. France Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 15. France Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 16. France: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 17. France Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 18. France Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 20. Italy Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 21. Italy Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 23. Italy Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 24. Italy Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 25. Spain Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 26. Spain Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 27. Spain Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 28. Spain: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 29. Spain Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 30. Spain Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Europe Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Europe Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Europe: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 35. Rest of Europe Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 36. Rest of Europe Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 37. Recent Inorganic Growth Strategies in the Europe immunodiagnostics market
Table 38. Recent Organic Growth Strategies in the Europe immunodiagnostics market
Table 39. Glossary of Terms, Europe Immunodiagnostics Market

List Of Figures

Figure 1. Europe Immunodiagnostics Market Segmentation
Figure 2. Europe Immunodiagnostics Market, by Country
Figure 3. Europe Immunodiagnostics Market Overview
Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in Europe Immunodiagnostics Market
Figure 5. The UK Expected to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. Europe Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe Immunodiagnostics Market - Revenue Forecast and Analysis - 2021-2030
Figure 10. Europe Immunodiagnostics Market, by Product, 2022 & 2030 (%)
Figure 11. Enzyme-linked Immunosorbent Assays (ELISA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 12. Chemiluminescence Immunoassays (CLIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 13. Vitamin D Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 14. HIV Detection: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 15. HIV Ag/Ab Combo Assay: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 16. Other Tests: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 17. Radioimmunoassays (RIA): Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
Figure 20. Infectious Diseases: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 21. COVID-19: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 22. Tuberculosis: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 23. Lyme: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 24. Infection Management: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 25. Zika: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 26. Treponema: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 27. TORCH: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 28. Measles and Mumps: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 29. VZV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 30. EBV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 31. Hepatitis+HIV: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 32. Gastrointestinal: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 33. Metabolics: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 34. Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 35. Hypertension: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 36. Growth: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 37. Diabetes: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 38. Thyroid: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 39. Reproductive Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 40. Endocrinology: Europe Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 41. Europe Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
Figure 42. Hospitals: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 43. Clinics: Europe Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)
Figure 44. Diagnostic Laboratories: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 45. Academic and Research Institutes: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 46. Others: Europe Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 47. Europe: Immunodiagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 48. Europe: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 49. UK: Immunodiagnostics market - Revenue and Forecast to 2030 (US$ Million)
Figure 50. Germany: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 51. France: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 52. Italy: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 53. Spain: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 54. Rest of Europe: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)